1. Home
  2. ZVRA vs AGS Comparison

ZVRA vs AGS Comparison

Compare ZVRA & AGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • AGS
  • Stock Information
  • Founded
  • ZVRA 2006
  • AGS 2005
  • Country
  • ZVRA United States
  • AGS United States
  • Employees
  • ZVRA N/A
  • AGS N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • AGS Miscellaneous manufacturing industries
  • Sector
  • ZVRA Health Care
  • AGS Consumer Discretionary
  • Exchange
  • ZVRA Nasdaq
  • AGS Nasdaq
  • Market Cap
  • ZVRA 473.6M
  • AGS 455.5M
  • IPO Year
  • ZVRA 2015
  • AGS 2018
  • Fundamental
  • Price
  • ZVRA $9.09
  • AGS $11.66
  • Analyst Decision
  • ZVRA Strong Buy
  • AGS Hold
  • Analyst Count
  • ZVRA 7
  • AGS 4
  • Target Price
  • ZVRA $21.20
  • AGS $12.63
  • AVG Volume (30 Days)
  • ZVRA 677.5K
  • AGS 177.0K
  • Earning Date
  • ZVRA 11-12-2024
  • AGS 11-07-2024
  • Dividend Yield
  • ZVRA N/A
  • AGS N/A
  • EPS Growth
  • ZVRA N/A
  • AGS 150.52
  • EPS
  • ZVRA N/A
  • AGS 0.17
  • Revenue
  • ZVRA $24,489,000.00
  • AGS $386,033,000.00
  • Revenue This Year
  • ZVRA N/A
  • AGS $10.08
  • Revenue Next Year
  • ZVRA $318.48
  • AGS $4.97
  • P/E Ratio
  • ZVRA N/A
  • AGS $68.62
  • Revenue Growth
  • ZVRA 47.85
  • AGS 12.18
  • 52 Week Low
  • ZVRA $4.20
  • AGS $7.21
  • 52 Week High
  • ZVRA $9.30
  • AGS $11.75
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 59.84
  • AGS 57.26
  • Support Level
  • ZVRA $8.32
  • AGS $11.60
  • Resistance Level
  • ZVRA $9.27
  • AGS $11.72
  • Average True Range (ATR)
  • ZVRA 0.53
  • AGS 0.04
  • MACD
  • ZVRA 0.00
  • AGS -0.00
  • Stochastic Oscillator
  • ZVRA 81.82
  • AGS 51.75

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About AGS PlayAGS Inc.

PlayAGS Inc is a designer and supplier of gaming products and services for the gaming industry. The company mainly supplies electronic gaming machines (EGM), server-based systems and back-office systems which are used by casinos, and various gaming locations. Its operating segments are EGM, Table Products, and Interactive. The EGM segment offers a selection of video slot titles developed for the world-wide marketplace as well as EGM cabinets. Its Table Products segments include live proprietary table games and side bets, as well as ancillary table products. The Interactive segment consists of delivering games through mobile apps such as Lucky Play Casino and Vegas Fever. It earns a majority of its revenue from Electronic Gaming Machines segment and geographically from the United States.

Share on Social Networks: